Susan Chrolavicius

14.5k total citations · 4 hit papers
31 papers, 7.1k citations indexed

About

Susan Chrolavicius is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Susan Chrolavicius has authored 31 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 17 papers in Internal Medicine and 11 papers in Surgery. Recurrent topics in Susan Chrolavicius's work include Acute Myocardial Infarction Research (22 papers), Venous Thromboembolism Diagnosis and Management (17 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Susan Chrolavicius is often cited by papers focused on Acute Myocardial Infarction Research (22 papers), Venous Thromboembolism Diagnosis and Management (17 papers) and Antiplatelet Therapy and Cardiovascular Diseases (13 papers). Susan Chrolavicius collaborates with scholars based in Canada, United Kingdom and France. Susan Chrolavicius's co-authors include Salim Yusuf, Shamir R. Mehta, Keith A.A. Fox, Stefan H. Hohnloser, Basil S. Lewis, Ron J.G. Peters, Andrzej Budaj, Ingrid Copland, Feng Zhao and Madhu K. Natarajan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Susan Chrolavicius

31 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

2001 2.0k citations Shamir R. Mehta, Salim Yusuf et al. The Lancet profile →
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial

2011 1.4k citations Sanjit S. Jolly, Salim Yusuf et al. The Lancet profile →
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

2006 1.3k citations Susan Chrolavicius et al. The Lancet profile →
Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

2009 582 citations Shamir R. Mehta, Christopher B. Granger et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan Chrolavicius Canada	24	5.9k	2.7k	1.9k	1.4k	888	31	7.1k
E. Magnus Ohman United States	40	7.4k 1.3×	4.2k 1.5×	1.5k 0.8×	1.2k 0.8×	2.0k 2.3×	83	9.5k
Charles A. Herzog United States	49	5.3k 0.9×	2.3k 0.8×	480 0.3×	1.7k 1.2×	1.5k 1.7×	164	8.9k
Johannes C. Kelder Netherlands	37	4.5k 0.8×	2.7k 1.0×	915 0.5×	1.3k 0.9×	1.1k 1.2×	135	6.3k
Madhu K. Natarajan Canada	30	3.5k 0.6×	2.0k 0.7×	683 0.4×	886 0.6×	733 0.8×	128	4.7k
Vladimír Džavík Canada	41	4.2k 0.7×	4.3k 1.6×	484 0.3×	1.3k 0.9×	1.3k 1.5×	175	7.0k
Alexander G.G. Turpie Canada	40	6.8k 1.1×	2.6k 0.9×	5.8k 3.1×	567 0.4×	548 0.6×	114	8.7k
Ulrich Tebbe Germany	32	4.3k 0.7×	1.9k 0.7×	1.4k 0.7×	521 0.4×	1.2k 1.3×	202	5.6k
Saurav Chatterjee United States	38	3.0k 0.5×	956 0.4×	1.6k 0.9×	516 0.4×	457 0.5×	153	4.9k
Victor A. Ferraris United States	40	4.1k 0.7×	3.4k 1.3×	612 0.3×	1.3k 0.9×	396 0.4×	109	7.5k
Victor L. Serebruany United States	24	4.3k 0.7×	1.9k 0.7×	1.2k 0.6×	509 0.4×	343 0.4×	150	5.3k

Countries citing papers authored by Susan Chrolavicius

Since Specialization

Citations

This map shows the geographic impact of Susan Chrolavicius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Chrolavicius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Chrolavicius more than expected).

Fields of papers citing papers by Susan Chrolavicius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Chrolavicius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Chrolavicius. The network helps show where Susan Chrolavicius may publish in the future.

Co-authorship network of co-authors of Susan Chrolavicius

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Chrolavicius. A scholar is included among the top collaborators of Susan Chrolavicius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Chrolavicius. Susan Chrolavicius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Whitlock, Richard, P.J. Devereaux, Kevin Teoh, et al.. (2015). Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. The Lancet. 386(10000). 1243–1253. 239 indexed citations

Jolly, Sanjit S., Salim Yusuf, John A. Cairns, et al.. (2011). Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. The Lancet. 377(9775). 1409–1420. 1374 indexed citations breakdown →

Lamy, André, Peggy Gao, Susan Chrolavicius, et al.. (2011). The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial. Canadian Journal of Cardiology. 28(1). 95–101. 11 indexed citations

Jolly, Sanjit S., Kari Niemelä, Denis Xavier, et al.. (2011). Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. American Heart Journal. 161(2). 254–260.e4. 38 indexed citations

Lamy, André, P.J. Devereaux, Dorairaj Prabhakaran, et al.. (2011). Rationale and design of The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study: A large international randomized trial in cardiac surgery. American Heart Journal. 163(1). 1–6. 25 indexed citations

Steg, Philippe Gabríel, Shamir R. Mehta, Sanjit S. Jolly, et al.. (2010). Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux. American Heart Journal. 160(6). 1029–1034.e1. 13 indexed citations

Peters, Ron J.G., Salim Yusuf, Rizwan Afzal, et al.. (2010). Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. American Heart Journal. 160(6). 1049–1055. 11 indexed citations

Jolly, Sanjit S., David P. Faxon, Keith A.A. Fox, et al.. (2009). Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines. Journal of the American College of Cardiology. 54(5). 468–476. 46 indexed citations

Mehta, Shamir R., Christopher B. Granger, William E. Boden, et al.. (2009). Early versus Delayed Invasive Intervention in Acute Coronary Syndromes. New England Journal of Medicine. 360(21). 2165–2175. 582 indexed citations breakdown →

10.

Joyner, Campbell, Ron Peters, Rizwan Afzal, et al.. (2009). Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk. American Heart Journal. 157(3). 502–508. 23 indexed citations

11.

Bassand, Jean‐Pierre, R. Afzal, John W. Eikelboom, et al.. (2009). Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. European Heart Journal. 31(1). 50–58. 80 indexed citations

12.

Budaj, Andrzej, John W. Eikelboom, R. Afzal, et al.. (2008). Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. European Heart Journal. 30(6). 655–661. 127 indexed citations

13.

Peters, Ron J.G., Jean‐Pierre Bassand, R. Afzal, et al.. (2008). The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. European Heart Journal. 29(3). 324–331. 41 indexed citations

14.

Mehta, Shamir R., Jean‐Pierre Bassand, Susan Chrolavicius, et al.. (2008). Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy. American Heart Journal. 156(6). 1080–1088.e1. 95 indexed citations

15.

Mehta, Shamir R., Christopher B. Granger, John W. Eikelboom, et al.. (2007). Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 50(18). 1742–1751. 166 indexed citations

16.

Oldgren, Jonas, Lars Wallentin, R. Afzal, et al.. (2007). Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. European Heart Journal. 29(3). 315–323. 30 indexed citations

17.

Díaz, Rafael, Abhinav Goyal, Shamir R. Mehta, et al.. (2007). Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction. JAMA. 298(20). 2399–2399. 121 indexed citations

18.

Peters, Ron, Campbell Joyner, Jean‐Pierre Bassand, et al.. (2006). Abstract 3294: Fondaparinux versus Control (Placebo or Unfractionated Heparin) as an Adjunct to Thrombolytic Therapy in Acute Myocardial Infarction: an OASIS 6 Substudy. 114. 3 indexed citations

19.

Anand, Sonia S., Shamir R. Mehta, Maria Grazia Franzosi, et al.. (2005). Differences in the Management and Prognosis of Women and Men Who Suffer From Acute Coronary Syndromes. Journal of the American College of Cardiology. 46(10). 1845–1851. 225 indexed citations

20.

Mehta, Shamir R., William S. Weintraub, Bengt Jönsson, et al.. (2003). Incremental cost-effectiveness of early and long-term clopidogrel in patients undergoing percutaneous coronary infarction in the CURE trial: The PCI-CURE economic analysis. Journal of the American College of Cardiology. 41(6). 383–383. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact